Latin America has experienced rapid growth in all areas of clinical research, but despite this trend there remain gaps in understanding how to best run trials in the region. Pharm-Olam invites you to explore issues concerning the potential of Latin America for your drug development. With the highest population growth rate in the world (11.4%) and over 60 million people in its four largest metro areas. The region’s population and economy continue to boom, driving strong growth in pharmaceutical sales and research across all therapeutic areas.

Join us to learn about:
• How the region’s large urban centers allow sponsors to recruit patients quickly and with fewer active sites
• Lower treatment costs and fewer competing studies
• How Latin America differs from other world markets
• Regulatory changes and the best strategies for faster approval

South Africa continues to grow as the best nation to conduct clinical research in Africa. Learn about how South Africa’s diverse population and mix of public and private research hospitals make the country a strategic location for clinical trials across many therapeutic areas.

The discussion will also include a review of South African regulatory, FDA inspections, and the growing need for clinical research.

Unable to Attend?

Pharm-Olam can answer your questions about clinical research in Latin America and around the world. Let us evaluate your protocol to determine the actual incidence and patient availability.

Contact Pharm-Olam for free feasibility study

Dr. Jorge Fiuza is Senior Director of Latin American Operations at Pharm-Olam International. He is a qualified urologist and has over 16 years of experience managing clinical trials throughout Latin America, including management of the phase III trial for Viagra throughout the region.

Before joining Pharm-Olam he served with four multi-national pharmaceutical companies, two SMOs, and two global CROs in the region. He has experience managing over 30 trials across 10 therapeutic areas.

His experience involves regulatory expertise, clinical operations, project management across the countries in Latin American region.

Frans van Wyk manages Pharm-Olam’s South African operations. For the last decade Frans has been working in South Africa’s rapidly expanding CRO industry. This includes Project Management across all phases of clinical trials as well as a position as Director of Logistics for a South African SMO.

Mr. van Wyk has a degree in clinical pharmacology and is a qualified biomedical technologist.